financial results

Law firm investigates Chemed Corporation for potential securities violations after missing earnings guidance by $0.61 per share and $19.8 million in revenue.

Viridien reported strong 2025 results with 4% revenue growth and 21% EBITDA increase to $551 million. The company also announced leadership changes, appointing Henning Berg as new CEO.

Viridien reported strong 2025 results with 4% revenue growth and 21% EBITDA surge. Leadership transition sees Sophie Zurquiyah move to chair while Henning Berg becomes CEO.

Beauty Health (SKIN) will release Q4 2025 earnings March 12, 2026, followed by an investor call at 4:30 p.m. ET to discuss financial performance and guidance.

KN Energies reported 12% revenue growth to €105.2 million in 2025, with net profit surging 19% to €18.2 million, driven by strong liquid energy and LNG segments.

Law firm investigates Alight after company reported $800M goodwill impairment, missed earnings expectations, and triggered 35% stock decline.

CPS Technologies will report 2025 financial results on March 3, 2026 via investor conference call with CEO and CFO discussing annual performance.

Securities firm investigating ODDITY Tech after algorithmic glitch disrupted major ad partner, causing stock decline. Probe examines if company disclosed material information timely and adequately.

BrainsWay will release 2025 full-year financial results on March 11, 2026, followed by an 8:30 AM ET earnings call to discuss performance and operational updates.

Acacia Research will release full-year 2025 earnings on March 11, 2026, with a conference call at 8:00 a.m. ET.

Geron's RYTELO generated $184M in 2025 revenue. The company guides 2026 sales of $220-240M, driven by domestic expansion and international opportunities.

Katapult will release 2025 financial results March 11, 2026, without a conference call due to its pending all-stock merger with Aaron's Company and CCF Holdings.

Law firm investigates Camping World for potential securities violations after missing earnings expectations and suspending dividends. Shareholders encouraged to participate.

Law firm Pomerantz investigates Capital One for potential securities violations following disappointing Q4 earnings and 7.56% stock decline.

Exagen will release 2025 full-year results March 10, with preliminary unaudited results aligning with prior guidance. Company remains on track with financial projections.

Biodesix reports 24% full-year 2025 revenue growth to $88.5M, with Q4 surging 41% YoY. Company expects adjusted EBITDA positivity and plans investor roadshow.

Sasol returns to positive free cash flow despite flat revenue from lower commodity prices. EBITDA declined 12%, but cost discipline improved working capital management.

Three recent stock splitters—Netflix, Booking Holdings, and ServiceNow—show significant upside potential with analyst price targets suggesting 73%, 90%, and 149% gains respectively.

QVC Group extended its 2025 financial results release deadline beyond February 26, 2026, citing need for additional audit and consolidation time. No accounting issues indicated.

Euroseas will release Q4 2025 earnings on Feb. 25, 2026, followed by a live management call at 10 am ET to discuss financial performance and operational metrics.